SCHEMBL5667174

SCHEMBL5667174

O=C(O)CCc1cn(S(=O)(=O)c2cc(Cl)c(Cl)s2)c2ccc(-c3cccnc3)cc12

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 3/20 0.51
PPARG P37231 1/20 0.42
PPARD Q03181 1/20 0.42
PPARA Q07869 1/20 0.42
TBXAS1 P24557 1/20 0.38
NR4A2 P43354 1/20 0.37
P2RX7 Q99572 1/20 0.36
MKNK1 Q9BUB5 1/20 0.36
MKNK2 Q9HBH9 1/20 0.36
KRAS P01116 1/20 0.35
IDE P14735 2/20 0.35
MCL1 Q07820 1/20 0.35
CCNC P24863 1/20 0.35
CDK8 P49336 1/20 0.35
ACLY P53396 1/20 0.35
NR1D1 P20393 1/20 0.34
TACR1 P25103 1/20 0.34
CYP11B1 P15538 1/20 0.34
CYP11B2 P19099 1/20 0.34
PLA2G4A P47712 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5661426 0.90 HTR6 (0.59) HTR6PPARGPPARDPPARAACLY
SCHEMBL5659824 0.89 HTR6 (0.48) HTR6PPARGPPARDPPARATBXAS1
SCHEMBL5659462 0.85 HTR6 (0.47) HTR6PPARGPPARDPPARATBXAS1
SCHEMBL5659642 0.84 PPARG (0.49) HTR6PPARGPPARDPPARATBXAS1
SCHEMBL5659549 0.83 PPARG (0.40) HTR6PPARGPPARDPPARANR4A2
SCHEMBL5659296 0.83 HTR6 (0.51) HTR6PPARGPPARDPPARANR4A2
SCHEMBL5659177 0.82 PPARG (0.47) HTR6PPARGPPARDPPARATBXAS1
SCHEMBL4606773 0.82 TBXAS1 (0.46) HTR6PPARGPPARDPPARATBXAS1
SCHEMBL5664174 0.81 PPARG (0.44) HTR6PPARGPPARDPPARATBXAS1
SCHEMBL5661621 0.80 PPARG (0.53) HTR6PPARGPPARDPPARATBXAS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070072904-A1 1-arylsulfone-substituted indole carboxylic acids or amides; peroxisome proliferator-activated receptor PPAR modulators; obesity, diabetes, cardiovascular disorders PLEXXIKON INC 2007-03-29 US disclosed
US-20070072904-A1 1-arylsulfone-substituted indole carboxylic acids or amides; peroxisome proliferator-activated receptor PPAR modulators; obesity, diabetes, cardiovascular disorders PLEXXIKON INC 2007-03-29 US disclosed
WO-2007030559-A2 1, 3-DISUBSTITUTED INDOLE DERIVATIVES FOR USE AS PPAR MODULATORS PLEXXIKON, INC. (US) 2007-03-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070072904-A1 1-arylsulfone-substituted indole carboxylic acids or amides; peroxisome proliferator-activated receptor PPAR modulators; obesity, diabetes, cardiovascular disorders PPARG, PPARA, PPARD HTR6 178/4885PPARG 1/4885PPARD 3/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.